Just a week after the first official data on the impact of Germany’s cannabis reforms was published, the Federal Cabinet approved proposals to restrict medical cannabis prescriptions across the country.
Award-winning Frankfurt-based company Bloomwell Group GmbH (“Bloomwell Group”) today announced the launch of Germany’s largest centralised digital platform for medical cannabis with regards to participating users, creating a one-stop shop for patients, physicians, pharmacies and suppliers all under the Bloomwell brand name.
Germany’s highly anticipated CanG bill is now finally set to have its final reading in the Bundestag this week following months of doubt and delays.
LVR University Hospital Essen, in collaboration with Algea Care, Europe’s leading telehealth platform for cannabis, has announced the results of a groundbreaking study on the efficacy of medical cannabis in treating chronic depression: patients showed significant improvement, with the reported severity rate of their depression reduced significantly, with no severe side effects and a low…
Germany’s CanG bill has been delayed yet again, just days after reports emerged that the coalition parties and Ministry of Health had come to an agreement on some of its most contentious points.
Germany’s Ministry of Health has officially published its draft law for ‘Pillar 1’ of its plans to liberalise access to adult-use cannabis.
GERMANY’S cannabis proposals have been met with a mixed response with many businesses seemingly frozen out of the cannabis club programme and now focused on the ‘scientific’, pilot project.
DELAYS in submitting its proposals to the European Commission and potential hold-ups once submitted could see Germany’s adult-use cannabis plans pushed back into 2025.
FURTHER details on Germany’s proposed adult-use cannabis market are to be published soon, and they will be avidly consumed with much uncertainty currently surrounding the proposed reforms.
